Order Article Reprints

Delombaerde D, De Sutter J, Croes L, Vervloet D, Moerman V, Van de Veire N, Willems A-M, Wouters K, Peeters M, Prenen H, et al. Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study. Pharmaceuticals. 2023; 16(4):625. https://doi.org/10.3390/ph16040625

Delombaerde, Danielle, Johan De Sutter, Lieselot Croes, Delphine Vervloet, Veronique Moerman, Nico Van de Veire, Anne-Marie Willems, Kristien Wouters, Marc Peeters, Hans Prenen, and et al. 2023. "Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study" Pharmaceuticals 16, no. 4: 625. https://doi.org/10.3390/ph16040625

Delombaerde, D., De Sutter, J., Croes, L., Vervloet, D., Moerman, V., Van de Veire, N., Willems, A.-M., Wouters, K., Peeters, M., Prenen, H., & Vulsteke, C. (2023). Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study. Pharmaceuticals, 16(4), 625. https://doi.org/10.3390/ph16040625